Esperion Therapeutics, Inc. (ESPR)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 02:33PM EDT. Market open.
| Previous Close | 2.1200 |
| Open | 2.3850 |
| Bid | 2.4300 x 5800 |
| Ask | 2.4500 x 200 |
| Day's Range | 2.1300 - 2.5254 |
| 52 Week Range | 0.7000 - 3.4000 |
| Volume | |
| Avg. Volume | 6,095,429 |
| Market Cap | 463.085M |
| Beta (5Y Monthly) | 0.82 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Esperion Therapeutics Inc (ESPR) Surpasses Q1 Revenue Forecasts with a 467% Increase
Significant Growth and FDA Approvals Propel Performance
- Zacks
Esperion Therapeutics (ESPR) Q1 Earnings and Revenues Beat Estimates
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 525% and 159.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
© 2024 Yahoo. All rights reserved.